At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 697 enrolled
Drug / intervention
Non invasive cardiac imagingother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of Integrated Cardiac Imaging for the Detection and Characterization of Ischemic Heart Disease
Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy·interventional·Posted Sep 17, 2009·Updated Jul 21, 2014
In Brief
A Phase 4 clinical trial evaluating Non invasive cardiac imaging for Ischemic Heart Disease. Completed, enrolled 697 participants across 16 sites in 9 countries.
Detailed Summary
Main purpose of the study: To comparatively assess the diagnostic performance of non invasive anatomical and functional imaging modalities to detect significant obstructive coronary artery disease as demonstrated at invasive coronary angiography and functional evaluation of coronary lesions (fractional flow reserve).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsIschemic Heart Disease
CountriesFinland, France, Germany, Italy, Netherlands, Poland, Spain, Switzerland, United Kingdom
CollaboratorsEuropean Commission
Timeline
Phase 4CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartFeb 2009
First PostedSep 2009
Primary CompletionJul 2010
Study CompletionJun 2012
TodayJul 2026
First PostedSep 17, 2009
Enrollment StartFeb 1, 2009
Primary CompletionJul 1, 2010
Study CompletionJun 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 16.8 years ago
Interventions
Non invasive cardiac imagingother
Non invasive cardiac imaging consists of CTCA combined with one Stress Imaging Test